Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Atherosclerotic Plaque Characteristics Change by DCE-MRI With Alirocumab - a Pilot Study

NCT02992301 is registered in ClinicalTrials.gov with Westside Medical Associates of Los Angeles as lead sponsor.

NCT NCT02992301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02992301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Atherosclerotic Plaque Characteristics Change by DCE-MRI With Alirocumab - a Pilot Study
Lead sponsor
Westside Medical Associates of Los Angeles
Phase
Phase 4
Overall status
Unknown status
Start date
November 30, 2016
Completion date
November 30, 2019
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, hyperlipidemia